Evaluation of the awareness regarding Type 2 Diabetes, its management and adverse effects of the treatment among the patients with Type 2 Diabetes

Tatar, Banu; KOCA, Nizameddin; Ersoy, Canan

Evaluation of the awareness regarding Type 2 Diabetes, its management and adverse effects of the treatment among the patients with Type 2 Diabetes

Banu TATAR, (Bursa Yüksek İhtisas Eğitim ve Araştırma Hastanesi, İç Hastalıkları Kliniği, Bursa, Türkiye)

Nizameddin KOCA, (Bursa Yüksek İhtisas Eğitim ve Araştırma Hastanesi, İç Hastalıkları Kliniği, Bursa, Türkiye)

Canan ERSOY (Uludağ Üniversitesi, Tıp Fakültesi, Endokrinoloji ve Metabolizma Anabilim Dalı, Bursa, Türkiye)

Aile Hekimliği ve Palyatif Bakım

2 1

Yıl: 2019 Cilt: 4 Sayı: 3 Sayfa Aralığı: 102 - 107 Metin Dili: İngilizce İndeks Tarihi: 02-11-2020

Evaluation of the awareness regarding Type 2 Diabetes, its management and adverse effects of the treatment among the patients with Type 2 Diabetes

Öz:

Introduction: Diabetes Mellitus (DM) management requires not only continuous medical care but also risk reduction strategies to preventcomplications. Improving patients’ knowledge and awareness about DM and diabetes-related complications (DRC) is crucial for themanagement of DM. Increased awareness about DM and DRC, which leads to an eagerness to follow-up diet plans, and lifestyle modificationswould help us to establish patient-specific goals. In this study, we would like to determine the awareness levels of diabetic patients about DM,DM management and DRC.Methods: Total of 300 adult patients (179 female, 121 male) with type 2 Diabetes Mellitus (T2DM) were included in this study. The data wascollected through a survey based on face-to-face interviews. Total Survey score (TSP) for each participant was calculated by taking 1 point foreach correct answer and TSP interval was evaluated between 0-24 points..Results: The score of women was higher than that of men (14.72±3.14 vs. 13.07±3.30, p <0.001). Patients who did not work were more aware(14.53±3.22 vs. 13.64±3.31, p = 0.019). No significant difference in terms of awareness was observed between low educated and high-educatedparticipants. Patients who had insulin in their treatment combination, anti-hypertensive, and lipid-lowering drug user had significantly higherTSP scores. A significant correlation was observed in BMI, HC, DBP, and age of Diabetes with awareness.Conclusions: The mean awareness score of the patients who participated in our study was 14 points. Since the maximum score that can beobtained at the highest awareness level is 24, the awareness level of our patients can be evaluated as 58%. Considering the morbidity, mortalityand economic costs associated with diabetes, it can be said that more attention should be paid to patient education in order to achieve highertreatment success.

Anahtar Kelime:

Tip 2 Diyabet hastalarının hastalıkları, tedavisi ve tedavi yan etkileri hususundaki farkındalıklarının değerlendirilmesi

Öz:

Giriş: Diyabetes Mellitus (DM) tedavisi sadece sürekli tıbbi bakımı değil aynı zamanda komplikasyonlardan korunmak için risk azaltma stratejilerini de içerir. Hastaların DM ve diyabetle ilgili komplikasyonlar (DIK) hakkındaki bilgi ve farkındalıklarını artırmak, DM yönetimi için çok önemlidir. DM ve DIK ile ilgili farkındalık, hastaların diyet planlarına ve yaşam tarzı değişikliklerine uyumda daha istekli davranmalarını sağlayarak bizlerin hastaya özel hedefler belirlememize yardımcı olacaktır. Bu çalışmada diyabet hastalarının DM, DM yönetimi ve DIK hakkındaki farkındalık seviyelerini belirlemek istiyoruz.. Yöntem: Çalışmaya tip 2 Diyabetes Mellituslu (T2DM) toplam 300 yetişkin hasta (179 kadın, 121 erkek) dahil edildi. Veriler yüz yüze görüşmelere dayanan bir anket aracılığıyla toplanmıştır. Her bir katılımcı için toplam anket puanı (TAP), her bir doğru cevap 1 puan alınarak hesaplandı ve TAP aralığı 0-24 arasında değerlendirildi Bulgular: Kadınların puanı erkeklerin puanından yüksekti (14.72±3.14 vs. 13.07±3.30, p <0,001). Çalışmayan hastaların farkındalıkları daha yüksekti (14.53±3.22 vs. 13.64±3.31, p = 0,019). Düşük eğitimli ve yüksek eğitimli katılımcılar arasında farkındalık açısından anlamlı bir fark gözlenmedi. Tedavi kombinasyonlarında insülin, anti-hipertansif ve lipid düşürücü ilaç kullanan hastalarda TAP skorları anlamlı derecede yüksek bulundu. Vücut kitle indeksi, kalça çevresi, diyastolik kan basıncı ve diyabet yaşı ile farkındalık arasında anlamlı bir korelasyon olduğu gözlendi. Sonuç: Çalışmamıza katılan hastaların ortalama farkındalık puanı 14 puan olarak gözlendi. En yüksek farkındalık düzeyinde alınabilecek maksimum puan 24 olduğundan hastalarımızın farkındalık düzeyi %58 olarak değerlendirilebilir. Diyabete bağlı morbidite, mortalite ve ekonomik maliyetleri göz önüne alarak, daha yüksek tedavi başarısını elde etmek için hasta eğitimine daha fazla önem verilmesi gerektiği söylenebilir.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. International Diabetes Federation. IDF Diabetes Atlas. 8 ed. Belgium: International Diabetes Federation; 2017.
2. Chinenye S, Young E. Management of diabetes mellitus in developing countries. The relevance of post prandial hyperglycemia. Pak J Med Sci. 2011;27:677-81.
3. Mahmood K, Akhtar S, Haider I, Abbassi B, Jalib A, Salekeen S. Dietary misconceptions in Pakistani diabetic patients. Pak J Med Sci. 2011;27:128-32.
4. Grossman S. Management of type 2 diabetes mellitus in the elderly: role of the pharmacist in a multidisciplinary health care team. J Multidiscip Healthc. 2011;4:149-54. http://dx.doi.org/10.2147/JMDH.S21111.
5. Gunay T, Ulusel B, Velipasaoglu S, Unal B, Ucku R, Ozgener N. Factors affecting adult knowledge of diabetes in Narlidere Health District, Turkey. Acta Diabetol. 2006;43(4):142-7. http://dx.doi.org/10.1007/s00592-006-0230-6.
6. He X, Wharrad HJ. Diabetes knowledge and glycemic control among Chinese people with type 2 diabetes. Int Nurs Rev. 2007;54(3):280-7. http://dx.doi.org/10.1111/j.1466-7657.2007.00570.x.
7. Al-Adsani AM, Moussa MA, Al-Jasem LI, Abdella NA, Al-Hamad NM. The level and determinants of diabetes knowledge in Kuwaiti adults with type 2 diabetes. Diabetes Metab. 2009;35(2):121-8. http://dx.doi.org/10.1016/j.diabet.2008.09.005
8. Arslantas D, Unsal A, Metintas S, Koc F. Knowledge of diabetic patients about diabetes at the primary stage in Eskisehir, Turkey. Pak J Med Sci 2008;24(2):263-8.
9. Liu X, Li Y, Li L, Zhang L, Ren Y, Zhou H, et al. Prevalence, awareness, treatment, control of type 2 diabetes mellitus and risk factors in Chinese rural population: the RuralDiab study. Sci Rep. 2016;6:31426. http://dx.doi.org/10.1038/srep31426
10. Mosnier-Pudar H, Hochberg G, Eschwege E, Virally ML, Halimi S, Guillausseau PJ, et al. How do patients with type 2 diabetes perceive their disease? Insights from the French DIABASIS survey. Diabetes Metab. 2009;35(3):220-7. http://dx.doi.org/10.1016/j.diabet.2009.02.001
11. Rehman Zu, Irshad M, Khan I, Khan FA, Baig A, Gaohar QY. A Survey of Awareness Regarding Diabetes and its Management Among Patients with Diabetes in Peshawar, Pakistan. J Postgrad Med 2014;28(4):372-7. http://www.jpmi.org.pk/index.php/jpmi/article/view/1628
12. Caliskan D, Ozdemir O, Ocaktan E, Idil A. Evaluation of awareness of diabetes mellitus and associated factors in four health center areas. Patient Educ Couns. 2006;62(1):142-7. http://dx.doi.org/10.1016/j.pec.2005.06.018.
13. Azimi-Nezhad M, Ghayour-Mobarhan M, Parizadeh MR, Safarian M, Esmaeili H, Parizadeh SM, et al. Prevalence of type 2 diabetes mellitus in Iran and its relationship with gender, urbanisation, education, marital status and occupation. Singapore Med J. 2008;49(7):571-6. https://www.ncbi.nlm.nih.gov/pubmed/18695867.
14. McDonald M, Hertz RP, Unger AN, Lustik MB. Prevalence, awareness, and management of hypertension, dyslipidemia, and diabetes among United States adults aged 65 and older. J Gerontol A Biol Sci Med Sci. 2009;64(2):256-63. http://dx.doi.org/10.1093/gerona/gln016.
15. Kacerovsky-Bielesz G, Lienhardt S, Hagenhofer M, Kacerovsky M, Forster E, Roth R, et al. Sex-related psychological effects on metabolic control in type 2 diabetes mellitus. Diabetologia. 2009;52(5):781-8. http://dx.doi.org/10.1007/s00125-009-1318-7.

APA	Tatar B, KOCA N, Ersoy C (2019). Evaluation of the awareness regarding Type 2 Diabetes, its management and adverse effects of the treatment among the patients with Type 2 Diabetes. , 102 - 107.
Chicago	Tatar Banu,KOCA Nizameddin,Ersoy Canan Evaluation of the awareness regarding Type 2 Diabetes, its management and adverse effects of the treatment among the patients with Type 2 Diabetes. (2019): 102 - 107.
MLA	Tatar Banu,KOCA Nizameddin,Ersoy Canan Evaluation of the awareness regarding Type 2 Diabetes, its management and adverse effects of the treatment among the patients with Type 2 Diabetes. , 2019, ss.102 - 107.
AMA	Tatar B,KOCA N,Ersoy C Evaluation of the awareness regarding Type 2 Diabetes, its management and adverse effects of the treatment among the patients with Type 2 Diabetes. . 2019; 102 - 107.
Vancouver	Tatar B,KOCA N,Ersoy C Evaluation of the awareness regarding Type 2 Diabetes, its management and adverse effects of the treatment among the patients with Type 2 Diabetes. . 2019; 102 - 107.
IEEE	Tatar B,KOCA N,Ersoy C "Evaluation of the awareness regarding Type 2 Diabetes, its management and adverse effects of the treatment among the patients with Type 2 Diabetes." , ss.102 - 107, 2019.
ISNAD	Tatar, Banu vd. "Evaluation of the awareness regarding Type 2 Diabetes, its management and adverse effects of the treatment among the patients with Type 2 Diabetes". (2019), 102-107.

APA	Tatar B, KOCA N, Ersoy C (2019). Evaluation of the awareness regarding Type 2 Diabetes, its management and adverse effects of the treatment among the patients with Type 2 Diabetes. Aile Hekimliği ve Palyatif Bakım, 4(3), 102 - 107.
Chicago	Tatar Banu,KOCA Nizameddin,Ersoy Canan Evaluation of the awareness regarding Type 2 Diabetes, its management and adverse effects of the treatment among the patients with Type 2 Diabetes. Aile Hekimliği ve Palyatif Bakım 4, no.3 (2019): 102 - 107.
MLA	Tatar Banu,KOCA Nizameddin,Ersoy Canan Evaluation of the awareness regarding Type 2 Diabetes, its management and adverse effects of the treatment among the patients with Type 2 Diabetes. Aile Hekimliği ve Palyatif Bakım, vol.4, no.3, 2019, ss.102 - 107.
AMA	Tatar B,KOCA N,Ersoy C Evaluation of the awareness regarding Type 2 Diabetes, its management and adverse effects of the treatment among the patients with Type 2 Diabetes. Aile Hekimliği ve Palyatif Bakım. 2019; 4(3): 102 - 107.
Vancouver	Tatar B,KOCA N,Ersoy C Evaluation of the awareness regarding Type 2 Diabetes, its management and adverse effects of the treatment among the patients with Type 2 Diabetes. Aile Hekimliği ve Palyatif Bakım. 2019; 4(3): 102 - 107.
IEEE	Tatar B,KOCA N,Ersoy C "Evaluation of the awareness regarding Type 2 Diabetes, its management and adverse effects of the treatment among the patients with Type 2 Diabetes." Aile Hekimliği ve Palyatif Bakım, 4, ss.102 - 107, 2019.
ISNAD	Tatar, Banu vd. "Evaluation of the awareness regarding Type 2 Diabetes, its management and adverse effects of the treatment among the patients with Type 2 Diabetes". Aile Hekimliği ve Palyatif Bakım 4/3 (2019), 102-107.